CD20 MicroBeads, human

Name: CD20 MicroBeads, human
Availability: InStock

CD20 MicroBeads, human

CD20 MicroBeads were developed for positive selection or depletion of human CD20

⁺

B cells from different cell sources such as human PBMCs, bone marrow, cell cultures or lymphoid tissues.

Product data and images for CD20 MicroBeads, human

Figures

Figure 1

B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.

PBMCs before separation	Enriched CD20 ⁺ cells
View details CD20 MicroBeads, human Figure 1 B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.	View details CD20 MicroBeads, human Figure 1 B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.

Specifications for CD20 MicroBeads, human

Overview

CD20 MicroBeads were developed for positive selection or depletion of human CD20

⁺

B cells from different cell sources such as human PBMCs, bone marrow, cell cultures or lymphoid tissues.

Detailed product information

Background information

CD20 is a non-glycosylated transmembrane protein of 33–37 kDa that becomes heavily phosphorylated upon activation

^1,2

. It is expressed exclusively on B cells, including pre-B cells, naive, mature, and activated B cells, B cell blasts, and the majority of malignant B cells, but not on early B cell progenitors or plasma cells

^2,3

.

Downstream applications

Purified CD20

⁺

B cells may be used in cell biological studies, such as analysis of signal transduction, chemotaxis, allergen response, apoptosis, or in molecular studies, e.g., subset-specific microarrays.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

Resources for CD20 MicroBeads, human

Documents and Protocols

Brochures/posters

The complete portfolio for your B cell research - product quick guide

References for CD20 MicroBeads, human

Publications

Chang et al. (1996) Appl. Immunohistochem. 4: 1-15
Polyak et al. (2002) CD20 Workshop Panel report. In: Leucocyte typing VII, Oxford University Press.
Countouriotis, A. et al. (2002) Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 20: 215-229
Cragg, M. S. et al. (2002) Opposing properties of CD20 mAb. In: Leucocyte typing VII, Oxford University Press.

Data and images

Data and images for CD20 MicroBeads, human

Figures

Figure 1

B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.

PBMCs before separation	Enriched CD20 ⁺ cells
View details CD20 MicroBeads, human Figure 1 B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.	View details CD20 MicroBeads, human Figure 1 B cells were separated from PBMCs using CD20 MicroBeads and the autoMACS™ Separator.

Specifications

Specifications for CD20 MicroBeads, human

Overview

CD20 MicroBeads were developed for positive selection or depletion of human CD20

⁺

B cells from different cell sources such as human PBMCs, bone marrow, cell cultures or lymphoid tissues.

Detailed product information

Background information

CD20 is a non-glycosylated transmembrane protein of 33–37 kDa that becomes heavily phosphorylated upon activation

^1,2

. It is expressed exclusively on B cells, including pre-B cells, naive, mature, and activated B cells, B cell blasts, and the majority of malignant B cells, but not on early B cell progenitors or plasma cells

^2,3

.

Downstream applications

Purified CD20

⁺

B cells may be used in cell biological studies, such as analysis of signal transduction, chemotaxis, allergen response, apoptosis, or in molecular studies, e.g., subset-specific microarrays.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

Resources

Resources for CD20 MicroBeads, human

Documents and Protocols

Brochures/posters

The complete portfolio for your B cell research - product quick guide

References

References for CD20 MicroBeads, human

Publications

Chang et al. (1996) Appl. Immunohistochem. 4: 1-15
Polyak et al. (2002) CD20 Workshop Panel report. In: Leucocyte typing VII, Oxford University Press.
Countouriotis, A. et al. (2002) Cell surface antigen and molecular targeting in the treatment of hematologic malignancies. Stem Cells 20: 215-229
Cragg, M. S. et al. (2002) Opposing properties of CD20 mAb. In: Leucocyte typing VII, Oxford University Press.

Related products for
CD20 MicroBeads, human

3 products available

Seems like you are coming from USA!
Do you want to visit our website in your country?

CD20 MicroBeads, human

CD20 MicroBeads, human

Product data and images for CD20 MicroBeads, human

Figures

Figure 1